期刊文献+

放线菌FIM06-0063产生的安莎类化合物的分离、纯化及其结构鉴定 被引量:1

Isolation, purification, and structure identification of ansamycin compounds from Actinomycetes FIM06-0063
下载PDF
导出
摘要 目的分离、纯化、鉴定来自放线菌FIM06-0063发酵液中的安莎类化合物。方法采用大孔吸附柱层析、硅胶柱层析等方法对FIM06-0063菌株的次级代谢产物进行分离纯化,以紫外、质谱、核磁等方法对获得的组分进行结构鉴定。结果从FIM06-0063菌株发酵液中共分离到4个安莎类化合物,经波谱方法鉴定,分别为:9-甲氧基-安丝菌素P-3(9-methoxy-ansamitocinP-3,1),安丝菌素P-2(ansamitocin P-2,2),安丝菌素P-3(ansamitocin P-3,3)和安丝菌素P-4(ansamitocin P-4,4)。结论首次从微生物发酵液中分离得到化合物1,为一个新的天然产物。活性研究表明该化合物对HL60肿瘤细胞具有增殖抑制活性,其IC50值为72.68nmol/L。 Objective To isolate, purify and identify the structure of ansamycin compounds from the fermentation broth ofActinomycetes FIM06-0063. Methods The secondary metabolites were isolated and purified by macroporous resin column chromatography, silica gel chromatography and other ways. The chemical structures were identified by UV, MS and NMR spectra. Results Four compounds isolated from the fermentation broth of FIM06- 0063 were identified as 9-methoxy-ansamitocin P-3 (1), ansamitocin P-2 (2), ansamitocin P-3 (3) and ansamitocin P-4 (4) on the basis of spectral data. Conclusion Compound 1 is a new natural product isolated from the broth of strain FIM06-0063 and showes growth inhibitory activity against the tumor cell lines HL60 with IC50 values of 72.68nmol/L.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第1期36-40,共5页 Chinese Journal of Antibiotics
基金 国家"十一五"重大专项"微生物药物技术创新与新药创制产学研联盟"(2010ZX09401-403)的支持
关键词 放线菌 安丝菌素 分离纯化 结构鉴定 Actinomycete Ansamitocin Isolation and purification Structure identification
  • 相关文献

参考文献12

  • 1Kupchan S M,Komoda Y,Court W A. Maytansine,a novel antileukemic ansa macrolide from Maytenus ovatus[J].Journal of the American Chemical Society,1972.1354-1356.
  • 2Kupchan S M,Komoda Y,Branfman A R. Tumor inhibitors.122.The maytansinoids.Isolation,structural elucidation,and chemical interrelation of novel ansa macrolides[J].Journal of Organic Chemistry,1977,(14):2349-2357.
  • 3Sakai K,Ichikawa T,Yamada K. Antitumor principles in mosses:The first isolation and identification of maytansinoids,including a novel 15-methoxyansam-itocin P-3[J].Journal of Natural Products,1988.845-850.
  • 4Suwanborirux K,Chang C J,Spjut R W. Ansamitocin P-3,a maytansinoid,from Claopodium crispifolium and Anomodon attenuatus or associated actinomycetes[J].Experientia,1990.117-120.
  • 5Higashide E,Asai M,Ootsu K. Ansamitocin,a group of novel maytansinoid antibiotics with antitumour properties from Nocardia[J].Nature,1977.721-722.
  • 6Tanida S,Hasegawa T,Hatano K. Ansamitocins,maytansinoid antitumor antibiotics producing organism,fermentation,and antimicrobial activities[J].Journal of Antibiotics,1980,(02):192-198.
  • 7Stephen C A,Nicole M O,Peter D S. Antibody-drug conjugates:targeted drug delivery for cancer[J].Current Opinion in Chemical Biology,2010.529-537.
  • 8姚骏骅;刘明.HPLC-ESI/MS测定安丝菌素同系物[J]质谱学报,2008108-109.
  • 9Kupchan S M,Sneden A T,Branfman A T. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoid[J].Journal of Medicinal Chemistry,1978.31-37.
  • 10Izawa M,Tanida S,Asai M. Ansamitocin analogs from a mutant strain of Nocardia Ⅱ.isolation and structure[J].Journal of Antibiotics,1981,(05):496-506.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部